ADMAHealthcareSmall-Cap

ADMA BIOLOGICS, INC. Insider Trading Activity

Every SEC Form 4 insider transaction reported for ADMA BIOLOGICS, INC. (ADMA), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are ADMA insiders buying or selling?

ADMA BIOLOGICS, INC. insiders reported 40 open-market buys ($36.5M) and 38 sells ($77.6M) across 78 Form 4 filings — a net selling position of $41.1M.

Source: SEC EDGAR Form 4

Key Statistics (as of May 28, 2026)

Total Form 4 filings
78
SEC EDGAR
Insider filers
15
Insider buys (40)
$36.5M
Insider sells (38)
$77.6M

Insider sentiment

Net selling

Net insider flow of $41.1M in net selling. 3 insider buys in the last 90 days.

Recent ADMA insider transactions

DateInsiderRoleTypeSharesPriceValue
May 28, 2026Grossman Jerrold BDirectorPurchase6.4K$7.91$50.6K
May 14, 2026Grossman Jerrold BDirectorPurchase12.5K$8.01$100.1K
May 12, 2026Grossman Jerrold BDirectorPurchase12.5K$8.01$100.1K
Mar 18, 2026Adam S GrossmanPresident and CEOSale21.0K$15.16$318.4K
Mar 11, 2026Kaitlin M. Kestenberg-MessinaCOO and SVP, ComplianceSale10.1K$15.63$157.8K
Mar 9, 2026ELMS STEVEDirectorPurchase14.0K$15.53$217.4K
Feb 18, 2026Adam S GrossmanPresident and CEOSale21.0K$16.08$337.7K
Dec 17, 2025Adam S GrossmanPresident and CEOSale21.0K$19.79$415.6K
Nov 22, 2025Adam S GrossmanPresident and CEOSale21.0K$16.00$336.0K
Oct 25, 2025Adam S GrossmanPresident and CEOSale21.0K$16.00$336.0K
Sep 17, 2025Adam S GrossmanPresident and CEOSale21.0K$16.13$338.7K
Aug 16, 2025Adam S GrossmanPresident and CEOSale21.0K$16.88$354.5K
Jul 17, 2025Adam S GrossmanPresident and CEOSale21.0K$18.66$391.9K
Jun 19, 2025Adam S GrossmanPresident and CEOSale21.0K$20.81$437.0K
Jun 17, 2025ELMS STEVEDirectorSale425.6K$20.74$8.8M
Jun 12, 2025Lawrence P. GuiheenDirectorSale20.0K$20.96$419.2K
Jun 11, 2025Grossman Jerrold BDirectorSale10.0K$21.31$213.1K
May 24, 2025Lawrence P. GuiheenDirectorSale9.0K$20.29$182.6K
May 17, 2025Adam S GrossmanPresident and CEOSale21.0K$19.45$408.4K
Apr 17, 2025Adam S GrossmanPresident and CEOSale21.0K$21.46$450.7K
Mar 22, 2025Adam S GrossmanPresident and CEOSale21.0K$18.92$397.3K
Nov 23, 2024Brad L. TadeCFO and TreasurerSale15.0K$21.15$317.3K
Nov 23, 2024Adam S GrossmanPresident and CEOSale49.0K$21.10$1.0M
Sep 12, 2024Lawrence P. GuiheenDirectorSale9.0K$18.47$166.2K
Aug 31, 2024Kaitlin M. Kestenberg-MessinaCOO and SVP, ComplianceSale24.1K$16.90$408.1K

Showing the 25 most recent of 78 Form 4 filings for ADMA BIOLOGICS, INC..

Most active ADMA insiders

  • Adam S Grossman24 filings
  • Grossman Jerrold B13 filings
  • Brian Lenz7 filings
  • Joseph Edelman7 filings
  • Lawrence P. Guiheen6 filings

Ask anything about ADMA insider activity

Use Trabud's AI agent to query ADMA BIOLOGICS, INC.'s Form 4 history in plain English — "Show me ADMA CEO purchases this year" or compare it against any other ticker.

Open the AI agent

ADMA insider trading FAQ

Are ADMA BIOLOGICS, INC. insiders buying or selling?

Across 78 SEC Form 4 filings, ADMA BIOLOGICS, INC. (ADMA) insiders reported 40 open-market purchases totaling $36.5M and 38 sales totaling $77.6M. That is a net selling position of $41.1M.

How many insiders trade ADMA stock?

15 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for ADMA BIOLOGICS, INC.. The most recent filing was accepted on May 28, 2026.

Where does Trabud get ADMA insider trading data?

All ADMA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content